Most Recent
Foxtel wins opposition to ‘originals IQ’ trade mark
Foxtel has successfully opposed a research firm's bid to register 'originals IQ' as a trade mark, with a delegate finding it was similar to the pay TV giant’s mark for its iQ set top boxes.
GM hit with class action over allegedly defective Holden transmissions
General Motors is facing a class action over Holden vehicles allegedly fitted with faulty transmission systems over the last 13 years. 
Jetstar hits back at class action over COVID-19 flight credits
Jetstar has hit back at a class action over COVID-19 flights cancellations, denying that it used “unfair tactics” to avoid providing the refunds customers say they were owed.
Exactech class action continues settlement talks despite US bankruptcy
A class action against implant maker Exactech has been stayed in light of its US bankruptcy, but a carve out allows the firm that brought the case to continue settlement negotiations.
Construction PRO
High Court asked to weigh in on ‘public purpose’ for land acquisition
Transport for NSW has asked the High Court to weigh in on when land is acquired for a 'public purpose', in a dispute over the value of land acquired near the Western Sydney Airport.
Baker McKenzie partner returns from Hogan Lovells
Baker McKenzie has welcomed back a seasoned banking and finance partner after his five-year stint at Hogan Lovells came to an end when the firm decided to close its Sydney office. 
New Zealand’s highest court endorses early common fund orders
ANZ Bank New Zealand has lost its bid to appeal a ruling that common fund orders can be made in class actions, including at an early stage of the proceeding,
Chartered Accountants drops investigation into ex-PwC tax partner
Accounting disciplinary body Chartered Accountants ANZ has dropped its investigation into former PwC tax partner Wayne Plummer, who was linked to the firm's tax leaks scandal in 2023. 
Virbac loses bid to block generic animal drug
Animal health company Virbac has lost its interlocutory bid to block a generic version of its animal drug Cydectin Platinum by rival Abbey Laboratories.